Astmalääkityksen aiheuttama osteoporoosiriski

Liisa Rankinen, Hille Suojalehto, Ritva Piipari, Heikki Frilander, Timo Hannu

1. Sosiaali-ja terveysministeriön työryhmä. Astmaohjelma 1994-2004. Lääkärilehti 1994;49:2889.
2. Laitinen L, Stenius-Aarniala B, Haahtela T. Astma. Kirjassa: Kinnula V, Laitinen LA, Tukiainen P, toim. Keuhkosairaudet. Jyväskylä: Duodecim 2000; 268-79.
3. Suomalaisen Lääkäriseuran Duodecimin, Suomen Keuhkolääkäriyhdistys ry:n, Suomen Lastenlääkäriyhdistys ry:n ja Suomen Kliinisen fysiologian Yhdistys ry:n asettama työryhmä. Astma, Käypä hoito 19.5.2006.
4. NIH Consensus development panel on osteoporosis prevention, diagnosis, and therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285: 785-95.
5. Välimäki M. Murtumapotilaat ensimmäiseksi osteoporoosin hoidon piiriin, mutta miten? Duodecim 2001;117:2521-23.
6. Suomen Endokrinologiyhdistys. Osteoporoosi, Käypä hoito 18.7.2000. Http://www.terveysportti.fi.
7. Goldstein MF, Fallon JJ, Harning R. 1999. Chronic glucocorticoid therapy- induced osteoporosis in patients with obstructive lung disease. Chest 1999;116: 1733-49.
8. Ebeling PR, Erbas B, Hopper JL, Wark JD, Rubinfeld AR. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids. J Bone Miner Res 1998;13:1283-9.
9. Hodsman AB, Toogood JH, Jennings B, Fraher LJ, Baskerville JC. Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metabol 1991;72: 530-40.
10. Kerstjens HAM, Postma DS, Doormaal JJ ym. Effects of short term and long term  treatment with inhaled corticosterois on bone metabolism in patients with airways obstruction. Thorax 1994;49: 652-6.
11. Leech JA, Hodder RV, Ooi DS, Gay J. Effects of short-term inhaled budesonide and beclomethasone dipropionate on serum osteocalcin in premenopausal women. Am Rev Resp Dis 1993;148:113-5.
12. Tattersfield AE, Town GI, Ohnell O. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax 2001;56: 272-8.
13. Toogood JH, Jennings B, Hodsman AB, Baskerville J, Fraher LJ. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol 1991;88: 572-80.
14. Herrala J. Asthma, inhaled corticosteroids and bone. Väitöskirja. Acta Universitatis Tamperensis 549. 1997.
15. Ledford D, Apter A, Brenner AM ym. Osteoporosis in the corticosteroid-treated patient with asthma. J Allergy Clin Immunol 1998;102: 353-62.
16. Smith BJ, Phillips P, Heller RH. Asthma and chronic obstructive airway diseases are associated with osteoporosis and fractures: A literature review. Respirology 1999;4:101-9.
17. Lipworth BJ. Systemic Adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 1999;159: 941-55.
18. Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease (review). The Cochrane Database of Systematic Reviews 2002, Issue 1.Art. N.: CD003537. DOI:10.1002/14651858.CD003537.
19. Leone FT, Fish JE, Szefler SJ, West SL Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest 2003;124: 2329-40.
20. Melton LJ, Patel A, Achenbach SJ, Oberg AL, Yunginger JW. Long-term fracture risk following adult-onset asthma: a population-based study. Osteopor Int  2004;15: 311-16.